PRINCETON, N.J.— November 4, 2021 — Certara, Inc. (Nasdaq: CERT), a global leader in biosimulation, today announced that seven of the Company’s scientists have been featured in a list of the top 2% of scientists worldwide. The list was published on October 19, 2021 by Elsevier BV and Stanford University.
The ranking of scientists worldwide is based on a composite citation score or a percentile rank of 2% or above. Scientists are classified into 22 scientific fields and 176 sub-fields. The seven scientists at Certara, who were ranked on the list, were recognized in the fields of toxicology and pharmacology & pharmacy and a range of sub-fields, including endocrinology and metabolism, pediatrics, microbiology, chemistry, and medicinal and biomolecular.
“I would like to congratulate our scientific leaders not only for receiving this prestigious recognition but also for their significant contributions to pharmaceutical sciences and impact on drug development and ultimately patients,” said William F. Feehery, Ph.D., chief executive officer of Certara. “Science is at the foundation of what we do at Certara, and we have some of the world’s leading scientists working on the toughest challenges in drug development today.”
Certara accelerates medicines using proprietary biosimulation software and technology to transform traditional drug discovery and development. Its clients include more than 1,650 global biopharmaceutical companies, leading academic institutions, and key regulatory agencies across 61 countries.
Chief Strategy and Marketing Officer